Physician profile
Carl Walker
NPI 1053301440
$9,831.92
in general payments reported to CMS, 2019-2025
49 companies · $868 in 2025
The $868 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $837 · 2021: $2,646 · 2022: $1,260 · 2023: $2,073 · 2024: $1,223 · 2025: $868.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,009 · Travel and Lodging: $568 · Honoraria: $333 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,009.39 |
| Travel and Lodging | $567.80 |
| Honoraria | $332.63 |
| Education | $253.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,513.55 | 2021-2023 | Urolift |
| Axonics, INC. | $1,068.84 | 2020-2024 | Axonics |
| Procept Biorobotics Corporation | $845.24 | 2022-2025 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $731.56 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Sumitomo Pharma America, INC. | $633.36 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $595.45 | 2019-2025 | Xtandi, Myrbetriq |
| Neotract INC. | $443.53 | 2019-2020 | |
| Boston Scientific Corporation | $439.93 | 2021-2025 | Lithovue, Axonics, Lumenis Pulse 120h |
| Dendreon Pharmaceuticals LLC | $423.24 | 2019-2025 | Provenge |
| Abbvie INC. | $278.37 | 2021-2025 | Botox |
| Allergan, INC. | $215.80 | 2019-2021 | |
| Urogen Pharma, INC. | $187.46 | 2022-2025 | |
| Rochester Medical Corporation | $177.49 | 2022 | |
| Coloplast Corp | $171.24 | 2019-2023 | Coloplast Tfl Drive, Speedicath |
| Optinose US, INC. | $148.42 | 2019-2021 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.